Taizhou Dachen Pharmaceutical is a Chinese API and pharmaceutical intermediates manufacturer established in 2017, located in the Zhejiang Chemical API Base (Linhai Park). It is a subsidiary of the Richu Industrial Group. The company specializes in R&D, production, and sales of pharmaceutical raw materials, intermediates, and specialty chemicals. Key products include diacerein, aloe-emodin, rhein, minocycline HCl, tigecycline, and duloxetine HCl. They supply to Bayer, Merck, and other international pharma companies. FDA-registered for API manufacture with 2 inspections (1 NAI, 1 VAI). ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 certified. National high-tech enterprise designation.
Pharmaceutical intermediates, API production (diacerein, minocycline, tigecycline, duloxetine), custom chemical synthesis
1 site worldwide
Involvement in 6 clinical trials
No reviews available yet.
No documents available.